archetype (adl_version=1.5.1; rm_release=2.0.2; generated)
    CIMI-CORE-ITEM_GROUP.fatty_acid_oxidation_newborn_screen_panel.v1.0.0

specialize
    CIMI-CORE-ITEM_GROUP.laboratory_panel.v1

language
    original_language = <[ISO_639-1::en]>

description
    original_author = <
      ["name"] = <"Patrick Langford <patrick@neuronsong.com>">
      ["organisation"] = <"Intermountain Healthcare <http://intermountainhealthcare.org>">
    >
    details = <
      ["en"] = <
        language = <[ISO_639-1::en]>
        purpose = <"Archetype for CIMI 'Fatty acid oxidation newborn screen panel' concept">
        use = <"Use for Fatty acid oxidation newborn screen panel.">
        keywords = <"Fatty","acid","oxidation","newborn","screen","panel">
      >
    >
    lifecycle_state = <"unmanaged">
    other_contributors = <"Linda Bird <lbi@ihtsdo.org>","Joey Coyle <joey@xcoyle.com>","Stan Huff <Stan.Huff@imail.org>","Harold Solbrig <Solbrig.Harold@mayo.edu>","Thomas Beale <thomas.beale@oceaninformatics.com>">
    custodian_namespace = <"org.opencimi">
    custodian_organisation = <"Clinical Information Modeling Initiative <http://opencimi.org>">
    licence = <"Creative Commons CC-BY <https://creativecommons.org/licenses/by/3.0/>">
    copyright = <"Copyright (c) Clinical Information Modelling Initiative <http://opencimi.org>">
    ip_acknowledgements = <
      ["loinc"] = <"This content from LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use">
      ["snomed"] = <"This specification includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organization (IHTSDO). All rights reserved. SNOMED CT® was originally created by the College of American Pathologists. 'SNOMED' and 'SNOMED CT' are registered trademarks of the IHTSDO (www.ihtsdo.org). Use of any SNOMED CT content (including codes, identifiers, terms, expressions or derivatives) in any operational system (including any Data Creation System or Data Analysis System as defined in the SNOMED CT Affiliate License Agreement) is subject to the terms and conditions of the SNOMED CT Affiliate License (www.ihtsdo.org/license.pdf) or to a written variation to that agreement that has been agreed and formally executed between the IHTSDO and the Affiliate Licensee.">
    >
    conversion_details = <
      ["source_model"] = <"<http://s.details.loinc.org/LOINC/57084-6.html>">
      ["tool"] = <"loincer v0.0.1">
      ["time"] = <"2015-01-20T22:53:50">
    >

definition
    ITEM_GROUP[id1.1.1.1.1] matches { -- Fatty acid oxidation newborn screen panel
      /item[id5.0.2.1]/value[id0.0.102] matches {[at0.0.0.0.1]} -- Fatty acid oxidation newborn screen panel
      item matches {
          use_archetype ITEM_GROUP[id0.1.1.1.1, CIMI-CORE-ITEM_GROUP.carnitine_free__c0___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Carnitine free (C0) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.2, CIMI-CORE-ITEM_GROUP.decanoylcarnitine__c10___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Decanoylcarnitine (C10) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.3, CIMI-CORE-ITEM_GROUP.decenoylcarnitine__c10_1___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Decenoylcarnitine (C10:1) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.4, CIMI-CORE-ITEM_GROUP.dodecanoylcarnitine__c12___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Dodecanoylcarnitine (C12) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.5, CIMI-CORE-ITEM_GROUP.dodecenoylcarnitine__c12_1___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Dodecenoylcarnitine (C12:1) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.6, CIMI-CORE-ITEM_GROUP.glutarylcarnitine__c5_dc___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Glutarylcarnitine (C5-DC) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.7, CIMI-CORE-ITEM_GROUP.hexanoylcarnitine__c6___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Hexanoylcarnitine (C6) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.8, CIMI-CORE-ITEM_GROUP.linoleoylcarnitine__c18_2___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Linoleoylcarnitine (C18:2) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.9, CIMI-CORE-ITEM_GROUP.fatty_acid_oxidation_defects_newborn_screen_interpretation.v1] occurrences matches {0..1} -- Fatty acid oxidation defects newborn screen interpretation
          use_archetype ITEM_GROUP[id0.1.1.1.10, CIMI-CORE-ITEM_GROUP.3_hydroxybutyrylcarnitine__c4_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.11, CIMI-CORE-ITEM_GROUP.3_hydroxylinoleoylcarnitine__c18_2_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.12, CIMI-CORE-ITEM_GROUP.3_hydroxyoleoylcarnitine__c18_1_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.13, CIMI-CORE-ITEM_GROUP.3_hydroxypalmitoleylcarnitine__c16_1_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.14, CIMI-CORE-ITEM_GROUP.3_hydroxypalmitoylcarnitine__c16_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.15, CIMI-CORE-ITEM_GROUP.3_hydroxystearoylcarnitine__c18_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.16, CIMI-CORE-ITEM_GROUP.acetylcarnitine__c2___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Acetylcarnitine (C2) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.17, CIMI-CORE-ITEM_GROUP.3_hydroxytetradecanoylcarnitine__c14_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.18, CIMI-CORE-ITEM_GROUP.butyrylcarnitine_plus_isobutyrylcarnitine__c4___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.19, CIMI-CORE-ITEM_GROUP.butyryl_plus_isobutyrylcarn_per_c2_dbs_srto.v1] occurrences matches {0..1} -- Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.20, CIMI-CORE-ITEM_GROUP.butyryl_plus_isobutyrylcarn_per_c3_dbs_srto.v1] occurrences matches {0..1} -- Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.21, CIMI-CORE-ITEM_GROUP.butyryl_plus_isobutyrylcarn_per_c8_dbs_srto.v1] occurrences matches {0..1} -- Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.22, CIMI-CORE-ITEM_GROUP.3_hydroxyhexanoylcarnitine__c6_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.23, CIMI-CORE-ITEM_GROUP.octenoylcarnitine__c8_1___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Octenoylcarnitine (C8:1) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.24, CIMI-CORE-ITEM_GROUP.octanoylcarnitine__c8___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Octanoylcarnitine (C8) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.25, CIMI-CORE-ITEM_GROUP.octanoylcarnitine__c8__per_acetylcarnitine__c2___molar_ratio__in_dried_blood_spot.v1] occurrences matches {0..1} -- Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.26, CIMI-CORE-ITEM_GROUP.octanoylcarnitine__c8__per_decanoylcarnitine__c10___molar_ratio__in_dried_blood_spot.v1] occurrences matches {0..1} -- Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.27, CIMI-CORE-ITEM_GROUP.3ohoctanoyl_plus_malonylcarn_dbs_scnc.v1] occurrences matches {0..1} -- 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.28, CIMI-CORE-ITEM_GROUP.3ohoctanoyl_plus_malonylcarn_per_c10_dbs_srto.v1] occurrences matches {0..1} -- 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.29, CIMI-CORE-ITEM_GROUP.decadienoylcarnitine__c10_2___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Decadienoylcarnitine (C10:2) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.30, CIMI-CORE-ITEM_GROUP.3_hydroxydecenoylcarnitine__c10_1_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.31, CIMI-CORE-ITEM_GROUP.glut_plus_3ohdecanoylcarn_dbs_scnc.v1] occurrences matches {0..1} -- Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.32, CIMI-CORE-ITEM_GROUP.glut_plus_3ohdecanoylcarn_per_c5oh_dbs_srto.v1] occurrences matches {0..1} -- Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.33, CIMI-CORE-ITEM_GROUP.glut_plus_3ohdecanoylcarn_per_c8_dbs_srto.v1] occurrences matches {0..1} -- Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.34, CIMI-CORE-ITEM_GROUP.glut_plus_3ohdecanoylcarn_per_c16_dbs_srto.v1] occurrences matches {0..1} -- Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.35, CIMI-CORE-ITEM_GROUP.3_hydroxydodecenoylcarnitine__c12_1_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.36, CIMI-CORE-ITEM_GROUP.3_hydroxydodecanoylcarnitine__c12_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.37, CIMI-CORE-ITEM_GROUP.tetradecadienoylcarnitine__c14_2___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.38, CIMI-CORE-ITEM_GROUP.tetradecenoylcarnitine__c14_1___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Tetradecenoylcarnitine (C14:1) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.39, CIMI-CORE-ITEM_GROUP.tetradecanoylcarnitine__c14___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Tetradecanoylcarnitine (C14) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.40, CIMI-CORE-ITEM_GROUP.tetradecenoylcarnitine__c14_1__per_acetylcarnitine__c2___molar_ratio__in_dried_blood_spot.v1] occurrences matches {0..1} -- Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.41, CIMI-CORE-ITEM_GROUP.tdecenoylcarn_per_c12_1_dbs_srto.v1] occurrences matches {0..1} -- Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.42, CIMI-CORE-ITEM_GROUP.tdecenoylcarn_per_c16_dbs_srto.v1] occurrences matches {0..1} -- Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.43, CIMI-CORE-ITEM_GROUP.3_hydroxytetradecadienoylcarnitine__c14_2_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.44, CIMI-CORE-ITEM_GROUP.3_hydroxytetradecenoylcarnitine__c14_1_oh___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- 3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.45, CIMI-CORE-ITEM_GROUP.palmitoleylcarnitine__c16_1___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Palmitoleylcarnitine (C16:1) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.46, CIMI-CORE-ITEM_GROUP.palmitoylcarnitine__c16___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.47, CIMI-CORE-ITEM_GROUP.3oh_palmitoylcarn_per_c16_dbs_srto.v1] occurrences matches {0..1} -- 3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.48, CIMI-CORE-ITEM_GROUP.oleoylcarnitine__c18_1___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Oleoylcarnitine (C18:1) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.49, CIMI-CORE-ITEM_GROUP.carnitine_free__c0__per_palmitoylcarnitine__c16___molar_ratio__in_dried_blood_spot.v1] occurrences matches {0..1} -- Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.50, CIMI-CORE-ITEM_GROUP.carnitine_free__c0__per_stearoylcarnitine__c18___molar_ratio__in_dried_blood_spot.v1] occurrences matches {0..1} -- Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.51, CIMI-CORE-ITEM_GROUP.carnitine_free_per_c16_plus_c18_dbs_srto.v1] occurrences matches {0..1} -- Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.52, CIMI-CORE-ITEM_GROUP.c0_plus_c2_plus_c3_plus_c16_plus_c18_per_cit_dbs_srto.v1] occurrences matches {0..1} -- Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.53, CIMI-CORE-ITEM_GROUP.stearoylcarnitine__c18___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Stearoylcarnitine (C18) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.54, CIMI-CORE-ITEM_GROUP.stearoylcarnitine__c18__per_propionylcarnitine__c3___molar_ratio__in_dried_blood_spot.v1] occurrences matches {0..1} -- Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.55, CIMI-CORE-ITEM_GROUP.3ohoctanoyl_plus_malonylcarn_per_c4_dbs_srto.v1] occurrences matches {0..1} -- 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.56, CIMI-CORE-ITEM_GROUP.glut_plus_3ohdecanoylcarn_per_c4_dbs_srto.v1] occurrences matches {0..1} -- Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.57, CIMI-CORE-ITEM_GROUP.malonylcarnitine__c3_dc___moles_per_volume__in_dried_blood_spot.v1] occurrences matches {0..1} -- Malonylcarnitine (C3-DC) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.58, CIMI-CORE-ITEM_GROUP.fatty_acid_oxidation_defects_newborn_screening_comment_discussion.v1] occurrences matches {0..1} -- Fatty acid oxidation defects newborn screening comment-discussion
          use_archetype ITEM_GROUP[id0.1.1.1.59, CIMI-CORE-ITEM_GROUP.fatty_acid_oxidation_conditions_suspected__identifier__in_dried_blood_spot.v1] occurrences matches {0..1} -- Fatty acid oxidation conditions suspected [Identifier] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.60, CIMI-CORE-ITEM_GROUP.tdecenoylcarn_per_c14_dbs_srto.v1] occurrences matches {0..1} -- Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.61, CIMI-CORE-ITEM_GROUP.c3_plus_c16_dbs_scnc.v1] occurrences matches {0..1} -- Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.62, CIMI-CORE-ITEM_GROUP.malonylcarnitine__c3_dc__per_decanoylcarnitine__c10___molar_ratio__in_dried_blood_spot.v1] occurrences matches {0..1} -- Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.1.1.63, CIMI-CORE-ITEM_GROUP.malonyl_plus_3ohbutyrylcarn_per_c10_dbs_srto.v1] occurrences matches {0..1} -- Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot
          use_archetype ITEM_GROUP[id0.1.2.1, CIMI-CORE-ITEM_GROUP.laboratory_panel.v1] occurrences matches {0}
      }
    }
terminology
  term_definitions = <
    ["en"] = <
      ["id1.1.1.1.1"] = <text = <"Fatty acid oxidation newborn screen panel">>
      ["at0.0.0.0.1"] = <text = <"Fatty acid oxidation newborn screen panel">>
      ["id0.1.1.1.1"] = <text = <"Carnitine free (C0) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.2"] = <text = <"Decanoylcarnitine (C10) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.3"] = <text = <"Decenoylcarnitine (C10:1) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.4"] = <text = <"Dodecanoylcarnitine (C12) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.5"] = <text = <"Dodecenoylcarnitine (C12:1) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.6"] = <text = <"Glutarylcarnitine (C5-DC) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.7"] = <text = <"Hexanoylcarnitine (C6) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.8"] = <text = <"Linoleoylcarnitine (C18:2) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.9"] = <text = <"Fatty acid oxidation defects newborn screen interpretation">>
      ["id0.1.1.1.10"] = <text = <"3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.11"] = <text = <"3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.12"] = <text = <"3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.13"] = <text = <"3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.14"] = <text = <"3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.15"] = <text = <"3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.16"] = <text = <"Acetylcarnitine (C2) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.17"] = <text = <"3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.18"] = <text = <"Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.19"] = <text = <"Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.20"] = <text = <"Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.21"] = <text = <"Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.22"] = <text = <"3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.23"] = <text = <"Octenoylcarnitine (C8:1) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.24"] = <text = <"Octanoylcarnitine (C8) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.25"] = <text = <"Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.26"] = <text = <"Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.27"] = <text = <"3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.28"] = <text = <"3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.29"] = <text = <"Decadienoylcarnitine (C10:2) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.30"] = <text = <"3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.31"] = <text = <"Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.32"] = <text = <"Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.33"] = <text = <"Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.34"] = <text = <"Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.35"] = <text = <"3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.36"] = <text = <"3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.37"] = <text = <"Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.38"] = <text = <"Tetradecenoylcarnitine (C14:1) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.39"] = <text = <"Tetradecanoylcarnitine (C14) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.40"] = <text = <"Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.41"] = <text = <"Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.42"] = <text = <"Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.43"] = <text = <"3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.44"] = <text = <"3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.45"] = <text = <"Palmitoleylcarnitine (C16:1) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.46"] = <text = <"Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.47"] = <text = <"3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.48"] = <text = <"Oleoylcarnitine (C18:1) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.49"] = <text = <"Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.50"] = <text = <"Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.51"] = <text = <"Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.52"] = <text = <"Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.53"] = <text = <"Stearoylcarnitine (C18) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.54"] = <text = <"Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.55"] = <text = <"3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.56"] = <text = <"Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.57"] = <text = <"Malonylcarnitine (C3-DC) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.58"] = <text = <"Fatty acid oxidation defects newborn screening comment-discussion">>
      ["id0.1.1.1.59"] = <text = <"Fatty acid oxidation conditions suspected [Identifier] in Dried blood spot">>
      ["id0.1.1.1.60"] = <text = <"Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.61"] = <text = <"Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot">>
      ["id0.1.1.1.62"] = <text = <"Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot">>
      ["id0.1.1.1.63"] = <text = <"Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot">>
    >
  >
  term_bindings = <
    ["loinc"] = <
      items = <
        ["id1.1.1.1.1"] = <http://loinc.org/id/57084-6> -- Fatty acid oxidation newborn screen panel
        ["at0.0.0.0.1"] = <http://loinc.org/id/57084-6> -- Fatty acid oxidation newborn screen panel
        ["id0.1.1.1.1"] = <http://loinc.org/id/38481-8> -- Carnitine free (C0) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.2"] = <http://loinc.org/id/45197-1> -- Decanoylcarnitine (C10) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.3"] = <http://loinc.org/id/45198-9> -- Decenoylcarnitine (C10:1) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.4"] = <http://loinc.org/id/45199-7> -- Dodecanoylcarnitine (C12) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.5"] = <http://loinc.org/id/45200-3> -- Dodecenoylcarnitine (C12:1) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.6"] = <http://loinc.org/id/45207-8> -- Glutarylcarnitine (C5-DC) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.7"] = <http://loinc.org/id/45211-0> -- Hexanoylcarnitine (C6) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.8"] = <http://loinc.org/id/45217-7> -- Linoleoylcarnitine (C18:2) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.9"] = <http://loinc.org/id/46736-5> -- Fatty acid oxidation defects newborn screen interpretation
        ["id0.1.1.1.10"] = <http://loinc.org/id/50102-3> -- 3-Hydroxybutyrylcarnitine (C4-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.11"] = <http://loinc.org/id/50109-8> -- 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.12"] = <http://loinc.org/id/50113-0> -- 3-Hydroxyoleoylcarnitine (C18:1-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.13"] = <http://loinc.org/id/50121-3> -- 3-Hydroxypalmitoleylcarnitine (C16:1-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.14"] = <http://loinc.org/id/50125-4> -- 3-Hydroxypalmitoylcarnitine (C16-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.15"] = <http://loinc.org/id/50132-0> -- 3-Hydroxystearoylcarnitine (C18-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.16"] = <http://loinc.org/id/50157-7> -- Acetylcarnitine (C2) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.17"] = <http://loinc.org/id/50281-5> -- 3-Hydroxytetradecanoylcarnitine (C14-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.18"] = <http://loinc.org/id/53166-5> -- Butyrylcarnitine+Isobutyrylcarnitine (C4) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.19"] = <http://loinc.org/id/53167-3> -- Butyrylcarnitine+Isobutyrylcarnitine (C4)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.20"] = <http://loinc.org/id/53168-1> -- Butyrylcarnitine+Isobutyrylcarnitine (C4)/Propionylcarnitine (C3) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.21"] = <http://loinc.org/id/53169-9> -- Butyrylcarnitine+Isobutyrylcarnitine (C4)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.22"] = <http://loinc.org/id/53173-1> -- 3-Hydroxyhexanoylcarnitine (C6-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.23"] = <http://loinc.org/id/53174-9> -- Octenoylcarnitine (C8:1) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.24"] = <http://loinc.org/id/53175-6> -- Octanoylcarnitine (C8) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.25"] = <http://loinc.org/id/53176-4> -- Octanoylcarnitine (C8)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.26"] = <http://loinc.org/id/53177-2> -- Octanoylcarnitine (C8)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.27"] = <http://loinc.org/id/53178-0> -- 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.28"] = <http://loinc.org/id/53179-8> -- 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.29"] = <http://loinc.org/id/53180-6> -- Decadienoylcarnitine (C10:2) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.30"] = <http://loinc.org/id/53182-2> -- 3-Hydroxydecenoylcarnitine (C10:1-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.31"] = <http://loinc.org/id/53183-0> -- Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.32"] = <http://loinc.org/id/53184-8> -- Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/3-Hydroxyisovalerylcarnitine (C5-OH) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.33"] = <http://loinc.org/id/53185-5> -- Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Octanoylcarnitine (C8) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.34"] = <http://loinc.org/id/53186-3> -- Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.35"] = <http://loinc.org/id/53188-9> -- 3-Hydroxydodecenoylcarnitine (C12:1-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.36"] = <http://loinc.org/id/53189-7> -- 3-Hydroxydodecanoylcarnitine (C12-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.37"] = <http://loinc.org/id/53190-5> -- Tetradecadienoylcarnitine (C14:2) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.38"] = <http://loinc.org/id/53191-3> -- Tetradecenoylcarnitine (C14:1) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.39"] = <http://loinc.org/id/53192-1> -- Tetradecanoylcarnitine (C14) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.40"] = <http://loinc.org/id/53193-9> -- Tetradecenoylcarnitine (C14:1)/Acetylcarnitine (C2) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.41"] = <http://loinc.org/id/53194-7> -- Tetradecenoylcarnitine (C14:1)/Dodecenoylcarnitine (C12:1) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.42"] = <http://loinc.org/id/53195-4> -- Tetradecenoylcarnitine (C14:1)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.43"] = <http://loinc.org/id/53196-2> -- 3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.44"] = <http://loinc.org/id/53197-0> -- 3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.45"] = <http://loinc.org/id/53198-8> -- Palmitoleylcarnitine (C16:1) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.46"] = <http://loinc.org/id/53199-6> -- Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.47"] = <http://loinc.org/id/53201-0> -- 3-Hydroxypalmitoylcarnitine (C16-OH)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.48"] = <http://loinc.org/id/53202-8> -- Oleoylcarnitine (C18:1) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.49"] = <http://loinc.org/id/53233-3> -- Carnitine free (C0)/Palmitoylcarnitine (C16) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.50"] = <http://loinc.org/id/53234-1> -- Carnitine free (C0)/Stearoylcarnitine (C18) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.51"] = <http://loinc.org/id/53235-8> -- Carnitine free (C0)/Palmitoylcarnitine (C16)+Stearoylcarnitine (C18) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.52"] = <http://loinc.org/id/53236-6> -- Carnitine.free (C0)+Acetylcarnitine (C2)+Propionylcarnitine (C3)+Palmitoylcarnitine (C16)+Oleoylcarnitine (C18:1)+Stearoylcarnitine (C18)/Citrulline [Molar ratio] in Dried blood spot
        ["id0.1.1.1.53"] = <http://loinc.org/id/53241-6> -- Stearoylcarnitine (C18) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.54"] = <http://loinc.org/id/53400-8> -- Stearoylcarnitine (C18)/Propionylcarnitine (C3) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.55"] = <http://loinc.org/id/53402-4> -- 3-Hydroxyoctanoylcarnitine (C8-OH)+Malonylcarnitine (C3-DC)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.56"] = <http://loinc.org/id/53403-2> -- Glutarylcarnitine (C5-DC)+3-Hydroxydecanoylcarnitine (C10-OH)/Butyrylcarnitine+Isobutyrylcarnitine (C4) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.57"] = <http://loinc.org/id/54462-7> -- Malonylcarnitine (C3-DC) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.58"] = <http://loinc.org/id/57709-8> -- Fatty acid oxidation defects newborn screening comment-discussion
        ["id0.1.1.1.59"] = <http://loinc.org/id/57792-4> -- Fatty acid oxidation conditions suspected [Identifier] in Dried blood spot
        ["id0.1.1.1.60"] = <http://loinc.org/id/70159-9> -- Tetradecenoylcarnitine (C14:1)/Tetradecanoylcarnitine (C14) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.61"] = <http://loinc.org/id/75211-3> -- Propionylcarnitine (C3)+Palmitoylcarnitine (C16) [Moles/volume] in Dried blood spot
        ["id0.1.1.1.62"] = <http://loinc.org/id/75212-1> -- Malonylcarnitine (C3-DC)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot
        ["id0.1.1.1.63"] = <http://loinc.org/id/75213-9> -- Malonylcarnitine (C3-DC)+3-Hydroxybutyrylcarnitine (C4-OH)/Decanoylcarnitine (C10) [Molar ratio] in Dried blood spot
      >
    >
  >
